Cargando…
Exploiting Current Understanding of Hypoxia Mediated Tumour Progression for Nanotherapeutic Development
Hypoxia is one of the most common phenotypes of malignant tumours. Hypoxia leads to the increased activity of hypoxia-inducible factors (HIFs), which regulate the expression of genes controlling a raft of pro-tumour phenotypes. These include maintenance of the cancer stem cell compartment, epithelia...
Autores principales: | Feng, Jie, Byrne, Niall M., Al Jamal, Wafa, Coulter, Jonathan A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6966647/ https://www.ncbi.nlm.nih.gov/pubmed/31835751 http://dx.doi.org/10.3390/cancers11121989 |
Ejemplares similares
-
Radiation Response in the Tumour Microenvironment: Predictive Biomarkers and Future Perspectives
por: Byrne, Niall M., et al.
Publicado: (2021) -
Enhanced nanoparticle delivery exploiting tumour-responsive formulations
por: Bennie, Lindsey A., et al.
Publicado: (2018) -
Exploiting tumour hypoxia and overcoming mutant p53 with tirapazamine.
por: Brown, J. M.
Publicado: (1998) -
Nanotherapeutics in the EU: an overview on current state and future directions
por: Hafner, Anita, et al.
Publicado: (2014) -
Progress in advanced nanotherapeutics for enhanced photodynamic immunotherapy of tumor
por: Wei, Xiao, et al.
Publicado: (2022)